The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2 Feb 2021 16:02

Britain records 1,449 deaths, 16,840 cases

LONDON, Feb 2 (Reuters) - Britain recorded 1,449 deaths within 28 days of a positive test for COVID-19 on Tuesday, up from 406 a day earlier, with a further 16,840 cases of the disease, a decrease from a day earlier.Official data showed that 9.65 ...

Read more
1 Feb 2021 10:56

UPDATE 1-China's Clover ends COVID-19 vaccine partnership with GSK

(Adds GSK-related background)BEIJING, Feb 1 (Reuters) - China's Clover Biopharmaceuticals said on Monday it has terminated its partnership with GlaxoSmithKline Plc to develop a COVID-19 vaccine using the British drug maker's adjuvant, even as earl...

Read more
1 Feb 2021 10:08

China's Clover ends COVID-19 vaccine partnership with GSK

BEIJING, Feb 1 (Reuters) - China's Clover Biopharmaceuticals said on Monday it has terminated its partnership with GlaxoSmithKline Plc (GSK) to develop a COVID-19 vaccine using the British drug maker's adjuvant.Clover has been testing two COVID-19...

Read more
27 Jan 2021 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2021 13:06

TOP NEWS: GSK, Vir And Eli Lilly To Test Covid-19 Antibody Combination

TOP NEWS: GSK, Vir And Eli Lilly To Test Covid-19 Antibody Combination

Read more
26 Jan 2021 18:00

UPDATE 1-Sanofi to help produce 100 mln Pfizer/BioNTech vaccine doses

(Adds quote, details, background)PARIS, Jan 26 (Reuters) - Sanofi will fill and pack millions of doses of Pfizer's COVID-19 vaccine from July in an effort to help meet the huge demand for the U.S. drugmaker's shots.The French company will aim to h...

Read more
26 Jan 2021 17:11

Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says

PARIS, Jan 26 (Reuters) - French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an intervie...

Read more
26 Jan 2021 09:35

BROKER RATINGS: Exane Raises Compass But Cuts InterContinental Hotels

BROKER RATINGS: Exane Raises Compass But Cuts InterContinental Hotels

Read more
26 Jan 2021 08:28

TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia

TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia

Read more
22 Jan 2021 06:58

TOP NEWS: Glaxo, Johnson & Johnson Long-Acting HIV Drug Approved In US

TOP NEWS: Glaxo, Johnson & Johnson Long-Acting HIV Drug Approved In US

Read more
20 Jan 2021 17:01

LONDON MARKET CLOSE: Stocks Rise As Biden Assumes US Presidency

LONDON MARKET CLOSE: Stocks Rise As Biden Assumes US Presidency

Read more
20 Jan 2021 14:22

UPDATE 2-Merck KGaA, GSK suffer lung cancer drug setback

* Key drug hopeful bintrafusp alfa flops in lung cancer trial* Merck, partner GSK say other trials continue for now* Blow for Merck's relatively small pharma unit (Adds comments on strategy, GSK statement)By Ludwig BurgerFRANKFURT, Jan 20 (Reuters)...

Read more
20 Jan 2021 14:22

UPDATE 1-Merck KGaA, GSK suffer lung cancer drug setback

(Adds details on drug, GSK)By Ludwig BurgerFRANKFURT, Jan 20 (Reuters) - Merck KGaA's drug development programme has suffered a setback with the most important clinical trial of its cancer drug hopeful bintrafusp alfa stopped because the treatment...

Read more
20 Jan 2021 14:08

TOP NEWS: Glaxo And Merck KGaA Discontinue Bintrafusp Alfa Trial

TOP NEWS: Glaxo And Merck KGaA Discontinue Bintrafusp Alfa Trial

Read more
20 Jan 2021 12:32

Merck KGaA stops lung cancer trial testing drug hopeful bintrafusp alfa

FRANKFURT, Jan 20 (Reuters) - Germany's Merck KGaA said the most important clinical trial testing its cancer drug hopeful bintrafusp alfa, which it is co-developing with GlaxoSmithKline, would be stopped because the treatment does not appear to w...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.